There’s a new power player at CVS
America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...
CVS Health shares fell Friday as the pharmacy and healthcare company announced an immediate change at CEO, with company ...
CVS stock is lower Friday after the embattled healthcare company said Karen Lynch is out as CEO, effective immediately.
To arrest that rise, and boost sales and profits at its retail pharmacy division, CVS said Friday that it has replaced CEO ...
The pharma chain giant recently engaged strategic advisors about possibly breaking off its insurance and retail business.
Longtime executive David Joyner, 60, took over on Thursday after CVS repeatedly missed earnings targets, setting off unrest ...
Healthcare reform will likely remain a recurring political topic until universal, affordable coverage is achieved in the US, and CVS' stock may experience volatility if scenarios that threaten its ...
CVS Health shares are trading lower by 3.8% during Tuesday's session. Health insurer stocks are down after UnitedHealth ...
On Thursday, CVS Health Corp (CVS) stock saw a decline, ending the day at $63.67 which represents a decrease of $-1.35 or -2.08% from the prior close of $65.02. The stock opened at $63.41 and touched ...
that level of consumer price transparency, without someone really taking a crucial look at the PBM." Watch the video above to hear why Davis is still Overweight on CVS's stock. To watch more ...
CVS said Wednesday that it's launching a multi-year productivity initiative. It also cut its outlook for the year as its health care benefits segment continues to face pressure. Ex-Olympics star ...
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CVS stock, giving a Buy rating today. Ann Hynes has given her Buy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback